(2S,3R)-3-Fluoro-2-methylazetidine hydrochloride, 97%, 5g

Rallonge, 14/23, 29/32, 130 mm, 1 pièce

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-one, 95.0%, 250mg

GalNAc beta(1-3)GlcNAc-beta-pNP>98.0%(HPLC)2mg

3-(2-Bromoimidazo[2,1-b]thiazol-6-yl)propanoic acid hydrochloride, 95.0%, 1g

(2S,4S)-1-(tert-Butoxycarbonyl)-4-phenylpyrrolidine-2-carboxylic acid, 95.0%, 5g

4-Amino-2-bromo-5-cyanopyrimidine, 97.0%, 1g

2-((4-Methyl-2-nitrophenyl)amino)ethanol, 95.0%, 100g

8-BROMO-1,5-NAPHTHYRIDINE-3-CARBOXYLIC ACID, 95.0%, 250mg

ETHYL 2-(N-METHOXY-N-METHYLAMINO)-2-OXOACETATE, 97.0%, 10g

(5-cyano-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid, 95.0%, 500mg

Ethyl 4-fluorophenylacetate, 95.0%, 100g

2,2'-Oxybis(ethylamine) dihydrochloride, 95.0%, 1g